首页 | 本学科首页   官方微博 | 高级检索  
     


Treatment of idiopathic sclerosing inflammation of the orbit (myositis) with infliximab
Authors:Sven Sahlin  Börje Lignell  Maria Williams  Maryam Dastmalchi  Abiel Orrego
Affiliation:1. St Erik’s Eye Hospital, Karolinska Institute, Stockholm, Sweden;2. ?HS, Mariehamn, ?land, Finland;3. Department of Rheumatology, Karolinska Hospital and Institute, Stockholm, Sweden;4. Department of Pathology, Karolinska Hospital and Institute, Stockholm, Sweden
Abstract:Purpose: We report the successful use of infliximab in a young patient with idiopathic sclerosing orbital inflammation (myositis). Methods: We describe the patient’s medical records and review the literature. Results: Idiopathic myositis in this patient could not be satisfactorily treated with corticosteroids or chemotherapy. Biopsy showed sclerosing orbital inflammation. The patient had a prompt and sustained response with infliximab and methotrexate treatment. Conclusions: Infliximab and methotrexate might be considered in patients with idiopathic sclerosing orbital inflammation (myositis).
Keywords:idiopathic orbital inflammation  infliximab  myositis  sclerosing orbital inflammation
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号